Cipla fell 2.27% to Rs 643 at 12:15 IST on BSE, with the stock extending post result fall after the company provided weak guidance.
Meanwhile, the S&P BSE Sensex was down 321.98 points or 1.23% at 25,943.26
On BSE, so far 74,452 shares were traded in the counter as against average daily volume of 1.83 lakh shares in the past one quarter.
The stock hit a high of Rs 650.20 and a low of Rs 639.05 so far during the day. The stock had hit a record high of Rs 752.45 on 10 March 2015. The stock had hit a 52-week low of Rs 572 on 15 June 2015.
The stock had outperformed the market over the past one month till 6 November 2015, falling 0.84% compared with 2.48% decline in the Sensex. The scrip, however, underperformed the market in past one quarter, sliding 8.95% as against Sensex's 7.18% decline.
Cipla's consolidated net profit rose 44.4% to Rs 431.24 crore on 24.6% growth in total income to Rs 3478.33 crore in Q2 September 2015 over Q2 September 2014. The company announced the result after market hours on Thursday, 5 November 2015.
Also Read
The stock had shed 0.08% to settle at Rs 657.95 on Friday, 6 November 2015. The stock fell 2.35% in two trading days from its close of Rs 658.50 on 5 November 2015. It fell 7.55% in eight trading days from a recent high of Rs 695.55 on 28 October 2015.
Cipla said that the Q2 September 2015 results include a one-off revenue from the USA market. Cipla said that current year figures include the relevant results of Cipla's subsidiaries from the date they became subsidiary of the company and therefore the corresponding figures for the previous period are not comparable.
At the time of announcing Q2 result, Cipla said that growth in second half of the year ending 31 March 2016 is likely to be lower than growth in first half of the year ended 30 September 2015. The company's outlook for the current financial year ending 31 March 2016 remains positive, Cipla said.
Cipla is a global pharmaceutical company. The company's portfolio includes over 1,500 products in various therapeutic categories with one quality standard globally.
Powered by Capital Market - Live News